UnitedHealth Group Inc. buy Royal Bank of Canada
Start price
16.10.23
/
50%
€510.00
Target price
16.10.24
€564.11
Performance (%)
1.27%
Price
23.07.24
€511.10
Summary
This prediction is currently active. With a performance of 1.27%, the BUY prediction by Royal_Bank_of_Canada for UnitedHealth Group Inc. is trending in the right direction. Dividends of €5.40 are taken into consideration when calculating the performance. This prediction currently runs until 16.10.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
UnitedHealth Group Inc. | 1.530% | 1.530% |
iShares Core DAX® | -0.116% | 1.953% |
iShares Nasdaq 100 | -2.733% | -1.273% |
iShares Nikkei 225® | -1.721% | 3.263% |
iShares S&P 500 | -1.527% | 0.194% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread UnitedHealth Group Inc. diskutieren
UnitedHealth Group Incorporated (NYSE: UNH) had its price target raised by analysts at Royal Bank of Canada from $572.00 to $596.00. They now have an "outperform" rating on the stock.
Ratings data for UNH provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for UnitedHealth Group Inc.
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€456.50
29.02.24
29.02.24
€551.42
28.02.25
28.02.25
12.77%
23.07.24
23.07.24
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€480.00
16.01.24
16.01.24
€547.55
16.01.25
16.01.25
7.24%
23.07.24
23.07.24
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€501.00
30.11.23
30.11.23
€546.23
30.11.24
30.11.24
3.09%
23.07.24
23.07.24
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€461.00
17.04.23
17.04.23
€542.27
17.04.24
17.04.24
-2.12%
18.04.24
18.04.24